UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the sale, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
UnitedHealth Group Stock Performance
UNH opened at $542.34 on Friday. The firm has a market cap of $508.81 billion, a PE ratio of 28.32, a P/E/G ratio of 1.64 and a beta of 0.77. The company has a quick ratio of 0.78, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The business has a fifty day simple moving average of $502.80 and a 200-day simple moving average of $497.24. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s revenue was up 12.6% compared to the same quarter last year. During the same period last year, the company posted $4.70 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 21.84 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
Analysts Set New Price Targets
UNH has been the topic of a number of research reports. Loop Capital initiated coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target on the stock. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $549.00 to $556.00 in a research report on Tuesday, July 19th. BMO Capital Markets raised their target price on UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. Morgan Stanley raised their target price on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Finally, UBS Group raised their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research report on Thursday, July 21st. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $582.50.
Institutional Trading of UnitedHealth Group
Hedge funds and other institutional investors have recently modified their holdings of the business. NorthCrest Asset Manangement LLC boosted its position in shares of UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after buying an additional 45 shares during the period. Domani Wealth LLC boosted its position in UnitedHealth Group by 0.7% during the first quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock valued at $1,806,000 after purchasing an additional 25 shares during the last quarter. Stratos Wealth Partners LTD. boosted its position in UnitedHealth Group by 44.0% during the first quarter. Stratos Wealth Partners LTD. now owns 17,711 shares of the healthcare conglomerate’s stock valued at $9,032,000 after purchasing an additional 5,414 shares during the last quarter. Salvus Wealth Management LLC boosted its position in UnitedHealth Group by 23.5% during the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock valued at $399,000 after purchasing an additional 149 shares during the last quarter. Finally, Lake Street Financial LLC boosted its position in UnitedHealth Group by 42.9% during the first quarter. Lake Street Financial LLC now owns 3,706 shares of the healthcare conglomerate’s stock valued at $1,890,000 after purchasing an additional 1,112 shares during the last quarter. Institutional investors and hedge funds own 87.48% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- MarketBeat: Week in Review 7/25 – 7/29
- Procter’s Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.